Cancer begins with a single glitch: a misplaced letter of the DNA code, which runs out of control, leading to uncontrolled cell growth. Traditional treatments, such as chemotherapy and radiation, target cancerous cells once they have emerged. CRISPR is different. It goes directly into the genes that created the issue in the first place. It’s turning the fight against cancer into one of precision, not destruction, by fixing those errors.

How CRISPR fixes broken genes

CRISPR was discovered in 2012 and works like a pair of molecular scissors. Scientists use a short guide RNA to find the faulty DNA segment that triggers cancer growth. The Cas9 enzyme then precisely cuts the faulty DNA segment, allowing the cell to repair itself using the correct code.  In 2023, a study published in Nature Biotechnology found that disabling tumor-driving genes with CRISPR slowed cancer growth in lab models. It is proof that the fight against cancer can now begin at its source, which is our genes.

CRISPR targets and corrects mutations in DNA

Let's say CRISPR is a GPS for the genome, the complete set of DNA that contains all the instructions for how our bodies grow and function. By finding the exact faulty gene, CRISPR can cut and correct it, helping stop diseases like cancer at their source. In 2020, a study published in Science showed how researchers also used CRISPR to engineer immune cells that can better recognize and attack cancer, giving the body’s natural defenses a smarter edge.

CRISPR trials show real hope

Some clinical trials of CRISPR-based therapies in people with leukemia, lymphoma, and lung cancer are underway. Initial findings indicate that modified immune cells can locate and eliminate tumors much more precisely. Scientists are also applying CRISPR to understand which genetic mutations cause every kind of cancer, leading to the creation of personalized medicine that suits the patient's DNA.

A future written in our genes

CRISPR is changing how we fight cancer, not just by easing symptoms, but by fixing the cause. The technology is still young, but its results already bring real hope. Others are combining it with immunotherapy to make immune cells stronger and more resistant to tumor defense. These breakthroughs bring us closer to earlier detection and more effective cancer treatment.